Literature DB >> 22610460

Functional (psychogenic) movement disorders.

Kathrin Czarnecki1, Mark Hallett.   

Abstract

PURPOSE OF REVIEW: This review provides an overview of recent developments in diagnosis, pathophysiology, neuroimaging and management of functional (psychogenic) movement disorders (FMD). RECENT
FINDINGS: There has been increasing interest to study the underlying pathophysiology of FMD, which has resulted in a broadened disease model, taking neurobiologic and psychosocial factors equally into account. In this context, the term 'psychogenic' has been replaced by 'functional' movement disorders by many authors in the field to express the changing focus toward a multifactorial disease model. The need for establishing a positive diagnosis of FMD as opposed to providing a diagnosis of exclusion is increasingly recognized and reflected by the introduction of 'laboratory-supported' diagnostic criteria of FMD. Important advances have been made through behavioral, electrophysiological and neuroimaging studies, although the fundamental cause of FMD remains poorly understood. Of particular interest have been several reports on abnormal sensorimotor features and cortical inhibition in both organic and functional dystonia, highlighting possible shared traits of both conditions. In terms of treatment, recent studies have reported benefit from both psychiatric and physical therapy-based interventions.
SUMMARY: Increasing efforts have been made toward better understanding of FMD, and the disease model has been broadened to include neurobiologic and psychosocial factors. Laboratory-based diagnostic criteria have been established for many FMD to support the clinical diagnosis. To determine the most effective management strategies for FMD, a closer collaboration between neurologists and psychiatrists and intensified research efforts with prospective treatment trials are needed.

Entities:  

Mesh:

Year:  2012        PMID: 22610460      PMCID: PMC4744646          DOI: 10.1097/WCO.0b013e3283551bc1

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  57 in total

1.  Cortical and spinal abnormalities in psychogenic dystonia.

Authors:  Alberto J Espay; Francesca Morgante; Jamie Purzner; Carolyn A Gunraj; Anthony E Lang; Robert Chen
Journal:  Ann Neurol       Date:  2006-05       Impact factor: 10.422

Review 2.  Conversion disorder: a problematic diagnosis.

Authors:  Timothy R J Nicholson; Jon Stone; Richard A A Kanaan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-29       Impact factor: 10.154

3.  Psychogenic dystonia.

Authors:  S Fahn; D T Williams
Journal:  Adv Neurol       Date:  1988

Review 4.  Phenomenology and psychopathology related to psychogenic movement disorders.

Authors:  D T Williams; B Ford; S Fahn
Journal:  Adv Neurol       Date:  1995

5.  Time of conscious intention to act in relation to onset of cerebral activity (readiness-potential). The unconscious initiation of a freely voluntary act.

Authors:  B Libet; C A Gleason; E W Wright; D K Pearl
Journal:  Brain       Date:  1983-09       Impact factor: 13.501

6.  Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study.

Authors:  A Feinstein; V Stergiopoulos; J Fine; A E Lang
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2001 Jul-Sep

7.  Antidepressant treatment outcomes of psychogenic movement disorder.

Authors:  Valerie Voon; Anthony E Lang
Journal:  J Clin Psychiatry       Date:  2005-12       Impact factor: 4.384

Review 8.  Treatment issues in psychogenic-neuropsychiatric movement disorders.

Authors:  Daniel T Williams; Blair Ford; Stanley Fahn
Journal:  Adv Neurol       Date:  2005

9.  Dystonia and tremor induced by peripheral trauma: predisposing factors.

Authors:  J Jankovic; C Van der Linden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

Review 10.  Functional (psychogenic) movement disorders: merging mind and brain.

Authors:  Mark J Edwards; Kailash P Bhatia
Journal:  Lancet Neurol       Date:  2012-03       Impact factor: 44.182

View more
  7 in total

Review 1.  Opinion: A role for placebo therapy in psychogenic movement disorders.

Authors:  Karen S Rommelfanger
Journal:  Nat Rev Neurol       Date:  2013-04-30       Impact factor: 42.937

Review 2.  Physiology-Based Treatment of Myoclonus.

Authors:  Ashley B Pena; John N Caviness
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 3.  Functional (psychogenic) movement disorders - Clinical presentations.

Authors:  Mark Hallett
Journal:  Parkinsonism Relat Disord       Date:  2015-09-03       Impact factor: 4.891

Review 4.  Treatment of myoclonus.

Authors:  John N Caviness
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

5.  A Simplified Version of the Psychogenic Movement Disorders Rating Scale: The Simplified Functional Movement Disorders Rating Scale (S-FMDRS).

Authors:  Glenn Nielsen; Luciana Ricciardi; Anne Marthe Meppelink; Kate Holt; Tiago Teodoro; Mark Edwards
Journal:  Mov Disord Clin Pract       Date:  2017-03-11

6.  BacAv, a new free online platform for clinical back-averaging.

Authors:  Felipe Vial; Sanaz Attaripour; Patrick McGurrin; Mark Hallett
Journal:  Clin Neurophysiol Pract       Date:  2020-01-25

7.  The chronnectome as a model for Charcot's 'dynamic lesion' in functional movement disorders.

Authors:  Ramesh S Marapin; A M Madelein van der Stouwe; Bauke M de Jong; Jeannette M Gelauff; Victor M Vergara; Vince D Calhoun; Jelle R Dalenberg; Yasmine E M Dreissen; Johannes H T M Koelman; Marina A J Tijssen; Harm J van der Horn
Journal:  Neuroimage Clin       Date:  2020-08-13       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.